Floatz logo

Mesna

Pro-Lymphocytic Leukemia

Center for International Blood and Marrow Transplant ResearchSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Pro-Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Center for International Blood and Marrow Transplant Research
Phase 2BBB
Fludarabine
Center for International Blood and Marrow Transplant Research
Phase 3BB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 3BB
FILGRASTIM
Center for International Blood and Marrow Transplant Research
Phase 2BB
TACROLIMUS
Center for International Blood and Marrow Transplant Research
Phase 2BB

View all 50 →

Same molecule, other indications

Mesna is also rated in:

Hodgkin's LymphomaDormant
BB
Indicative ·
69 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
69 / 100
View asset →
NK/T-cell LymphomaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →